Lucis
Lucis is a Paris-based preventive health platform that analyses over 110 blood biomarkers (covering metabolic health, hormones, cardiovascular risk, inflammation, and nutrients) and feeds the results into an AI-powered health companion app to deliver personalised guidance on nutrition, supplementation, and lifestyle changes. Founded in 2025 by Maxime Berthelot and Baptiste Debever, the company raised a $20M Series A led by Singular, with participation from General Catalyst and Y Combinator.
“Lucis raised $20M and is a 'health technology platform for biological age measurement and insights.'”
Source→“Lucis raised '$20M Series A from Singular, General Catalyst, YC' — a blood biomarker + AI metabolic health platform.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.